Search Results - "Buděšínský, Tomáš"
-
1
Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study
Published in Journal of translational medicine (30-01-2020)“…Bioresorbable scaffold (BRS) Absorb™ clinical use has been stopped due to higher rate of device thrombosis. Scaffold struts persist longer than 2 years in the…”
Get full text
Journal Article -
2
ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases
Published in European heart journal (01-07-2013)Get full text
Journal Article -
3
Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'
Published in European heart journal (01-03-2014)“…Bioresorbable vascular scaffolds (BVSs) have been studied in chronic coronary artery disease, but not in acute ST-segment elevation myocardial infarction…”
Get full text
Journal Article -
4
Immune–inflammatory response after bioresorbable vascular scaffold implantation in patients with acute myocardial infarction with ST elevation in a long-term perspective
Published in Heart and vessels (01-04-2019)“…A higher rate of bioresorbable vascular scaffold (BVS) thrombosis has been observed after device implantation compared to implantation of permanent metallic…”
Get full text
Journal Article -
5
Fully absorbable drug eluting coronary stent: where do we stand in 2014?
Published in Vnitřní lékar̆stvĭ (01-04-2014)“…Coronary stent is routinely used in majority percutaneous coronary interventions for a long time. They have an important role, especially, in the first months…”
Get more information
Journal Article -
6
Reverse Takotsubo syndrome, a rare form of "Broken Heart" syndrome
Published in Cor et vasa (English ed.) (01-11-2020)Get full text
Journal Article -
7
An anomalous origin and course of left anterior descending artery
Published in Cor et vasa (English ed.) (01-11-2020)Get full text
Journal Article -
8
Shock Index: A Simple Clinical Parameter for Quick Mortality Risk Assessment in Acute Myocardial Infarction
Published in Canadian journal of cardiology (01-11-2011)“…Abstract Background Primary percutaneous coronary intervention (PCI) has become the preferred reperfusion strategy in patients with ST-segment elevation…”
Get full text
Journal Article -
9
Might simplification of transcatheter aortic valve implantation reduce the burden on hospital resources?
Published in European heart journal supplements (01-04-2022)“…Transcatheter aortic valve implantation (TAVI) varies considerably in terms of the procedural approach taken and the hospital length of stay (LoS); both…”
Get full text
Journal Article -
10
Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update
Published in EuroIntervention (01-05-2016)“…Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-elevation myocardial infarction (STEMI) are encouraging, but…”
Get full text
Journal Article -
11
Nurse-led sedation for transfemoral transcatheter aortic valve implantation seems safe for a selected patient population
Published in European heart journal supplements (01-04-2022)“…Transcatheter aortic valve implantation (TAVI) has become a high-volume procedure with increasing demands on hospital resources. Local anaesthesia with…”
Get full text
Journal Article -
12
Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study
Published in Heart and vessels (01-06-2016)“…Incomplete stent apposition and uncovered struts are associated with a higher risk of stent thrombosis. No data exist on the process of neointimal coverage and…”
Get full text
Journal Article -
13
Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial
Published in Heart and vessels (01-11-2018)“…This study assessed the Optical Coherence Tomography (OCT) impact on the coronary flow in ST-elevation myocardial infarction (STEMI) after bioresorbable…”
Get full text
Journal Article -
14
Takotsubo Cardiomyopathy: One More Angiographic Evidence of Microvascular Dysfunction
Published in BioMed research international (01-01-2018)“…Background. Takotsubo cardiomyopathy (TC) aetiology has not been completely understood yet. One proposed pathogenic mechanism was coronary microvascular…”
Get full text
Journal Article -
15
Abstract 13551: Invasive Hemodynamic Assessment of Cardiac Output State After MitraClip Therapy
Published in Circulation (New York, N.Y.) (10-11-2015)“…IntroductionMitraClip therapy has become a therapeutic alternative for high surgical risk patients with symptomatic mitral regurgitation (MR). There are…”
Get full text
Journal Article -
16
Invasive Hemodynamic Assessment of Cardiac Output State after MitraClip Therapy in Nonanaesthetized Patients with Functional Mitral Regurgitation
Published in BioMed research international (01-01-2016)“…Background. Surgical correction of mitral regurgitation (MR) can lead to postoperative low cardiac output state. We aimed to assess the acute hemodynamic…”
Get full text
Journal Article -
17
One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: The PRAGUE-19 Study
Published in Circulation. Cardiovascular interventions (01-12-2015)“…BACKGROUND—Bioresorbable vascular scaffolds (BVS) represent promising new technology, but data on their long-term outcomes in ST-segment–elevation myocardial…”
Get full text
Journal Article -
18
One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial
Published in Circulation (New York, N.Y.) (30-11-2004)“…Off-pump coronary bypass surgery has become a widely used technique during recent years. However, limited data are available with regard to 1-year patency of…”
Get full text
Journal Article -
19
Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial
Published in European heart journal (01-03-2007)“…Aim Randomized trials in ST-elevation myocardial infarction (STEMI) showed improved early outcomes after primary percutaneous coronary intervention (p-PCI)…”
Get full text
Journal Article